Thứ tư, 16/03/2022 15:50 GMT+7

Biến thể của SARS-COV-2 (Ngày 04/03 - 11/03/2022)

Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu về các biến thể SARS-COV-2 hiện nay, bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SPRINGER NATURE

 

1. Casirivimab/imdevimab lack of efficacy against COVID-19 Omicron variant

Reactions Weekly (2022)

https://link.springer.com//content/pdf/10.1007%2Fs40278-022-08680-z.pdf

 

2. The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Jaffar A. Al-Tawfiq, Van-Thuan Hoang… in Journal of Epidemiology and Global Health (2022)

https://link.springer.com//content/pdf/10.1007%2Fs44197-022-00032-w.pdf

 

3. Omicron: a mysterious variant of concern

A. Gowrisankar, T. M. C. Priyanka, Santo Banerjee in The European Physical Journal Plus (2022)

https://link.springer.com//content/pdf/10.1140%2Fepjp%2Fs13360-021-02321-y.pdf

 

4. The Emergence of Omicron: Challenging Times Are Here Again!

Tanu Singhal in Indian Journal of Pediatrics (2022)

https://link.springer.com//content/pdf/10.1007%2Fs12098-022-04077-4.pdf

 

5. Role of Omicron variant of SARS-CoV-2 in children in Germany

Stefan Bittmann in World Journal of Pediatrics (2022)

https://link.springer.com//content/pdf/10.1007%2Fs12519-021-00511-3.pdf

 

6. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine… in BMC Medicine (2022)

https://link.springer.com//content/pdf/10.1186%2Fs12916-022-02312-5.pdf

 

7. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load

Jorge Quarleri, Veronica Galvan, M. Victoria Delpino in GeroScience (2022)

https://link.springer.com//content/pdf/10.1007%2Fs11357-021-00500-4.pdf

 

8. Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021

Jennifer Flechsler, Ute Eberle, Alexandra Dangel, Sabrina Hepner, Clara Wimmer… in Infection (2022)

https://link.springer.com//content/pdf/10.1007%2Fs15010-022-01767-1.pdf

 

9. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests

Andreas Osterman, Irina Badell, Elif Basara… in Medical Microbiology and Immunology (2022)

https://link.springer.com//content/pdf/10.1007%2Fs00430-022-00730-z.pdf

 

SCIENCEDIRECT

 

1. Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19

International Journal of Infectious Diseases, 4 February 2022, Volume 117 (Cover date: April 2022), Pages 139-145

Rachel Hui Fen LIM, Htet Lin HTUN, Angela CHOW

https://www.sciencedirect.com/science/article/pii/S1201971222000777/pdfft?md5=d85f1a6b582b59f45341c331e43c470b&pid=1-s2.0-S1201971222000777-main.pdf

 

2. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India

Microbial Pathogenesis, 19 January 2022, Volume 164 (Cover date: March 2022), Article 105404

Pushpendra Singh, Kuldeep Sharma, Nitin M. Nagarkar

https://www.sciencedirect.com/science/article/pii/S0882401022000171/pdfft?md5=ce9a8d3786a0a520ec844bf0b17ab391&pid=1-s2.0-S0882401022000171-main.pdf

 

3. Modeling and optimal control of mutated COVID-19 (Delta strain) with imperfect vaccination

Chaos, Solitons & Fractals, 31 January 2022, Volume 156 (Cover date: March 2022), Article 111825

Tingting Li, Youming Guo

https://www.sciencedirect.com/science/article/pii/S0960077922000364/pdfft?md5=582b7f8dbf65e45fa1d8f2c343b37011&pid=1-s2.0-S0960077922000364-main.pdf

 

4. Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China

International Journal of Infectious Diseases, 19 January 2022, Volume 116 (Cover date: March 2022), Pages 204-209

Zhiliang Hu, Bilin Tao, Jianming Wang

https://www.sciencedirect.com/science/article/pii/S1201971222000339/pdfft?md5=243821a5bcf29c0bf9a2d53fb665e894&pid=1-s2.0-S1201971222000339-main.pdf

 

5. Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: The Israeli case

Preventive Medicine, 17 November 2021 ,Volume 154 (Cover date: January 2022), Article 106890

Mor Saban, Vicki Myers, Rachel Wilf-Miron

https://www.sciencedirect.com/science/article/pii/S0091743521004631/pdfft?md5=86be23907a1169e9b05113116febfff6&pid=1-s2.0-S0091743521004631-main.pdf

 

6. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

The Lancet Regional Health - Europe, 28 October 2021, Volume 12 (Cover date: January 2022), Article 100252

Hester Allen, Amoolya Vusirikala, Meaghan Kall

https://www.sciencedirect.com/science/article/pii/S2666776221002386/pdfft?md5=d8ead76b2c31b593bf4284237a84cef1&pid=1-s2.0-S2666776221002386-main.pdf

 

7. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study

The Lancet Respiratory Medicine, Available online 25 February 2022, In press, corrected proof

Paul M McKeigue, David A McAllister, Helen M Colhoun

https://www.sciencedirect.com/science/article/pii/S2213260022000455/pdfft?md5=0879a789fe5fe944a329e8e64ec23c6e&pid=1-s2.0-S2213260022000455-main.pdf

 

8. Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas

The American Journal of Pathology, 11 November 2021, Volume 192, Issue 2 (Cover date: February 2022), Pages 320-331

Paul A. Christensen, Randall J. Olsen, James M. Musser

https://www.sciencedirect.com/science/article/pii/S0002944021004806/pdfft?md5=54059817be9e9c7d408a640ff6e90819&pid=1-s2.0-S0002944021004806-main.pdf

 

9. Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant

Mayo Clinic Proceedings, 16 December 2021, Volume 97, Issue 2 (Cover date: February 2022), Pages 327-332

John C. O’Horo, Douglas W. Challener, Raymund R. Razonable

https://www.sciencedirect.com/science/article/pii/S0025619621009241/pdfft?md5=1cadf5f488530d03a2ad4dddaf8c3ae1&pid=1-s2.0-S0025619621009241-main.pdf

 

10. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant

Pathology ,Available online 31 January 2022, In press, corrected proof

Adriana E. Rosato, Engy Msiha, Roberto R. Rosato

https://www.sciencedirect.com/science/article/pii/S0031302522000356/pdfft?md5=ca8997c9cc9944ab4fbd2a19b85de64c&pid=1-s2.0-S0031302522000356-main.pdf

 

11. Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou

International Journal of Infectious Diseases, 29 January 2022, Volume 117 (Cover date: April 2022), Pages 18-23

Xiaowei Ma, Keyi Wu, Xianbo Wu

https://www.sciencedirect.com/science/article/pii/S1201971222000364/pdfft?md5=c24edc9db32a52842d0f417ba3de8a3b&pid=1-s2.0-S1201971222000364-main.pdf

 

12. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants

eBioMedicine, 17 December 2021, Volume 75 (Cover date: January 2022), Article 103761

Rüdiger Groß, Michelle Zanoni, Janis A. Müller

https://www.sciencedirect.com/science/article/pii/S2352396421005557/pdfft?md5=84752304812a2d77efbff57e2892aa85&pid=1-s2.0-S2352396421005557-main.pdf

 

13. Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers

Clinical Microbiology and Infection, Available online 3 February 2022, In press, corrected proof

Louise Benning, Christian Morath, Claudius Speer

https://www.sciencedirect.com/science/article/pii/S1198743X22000350/pdfft?md5=23056daf8465068b4189dc1179fc96d9&pid=1-s2.0-S1198743X22000350-main.pdf

 

14. SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant

Infectious Disease Clinics of North America, Available online 1 February 2022, In press, journal pre-proof

Eric A. Meyerowitz, Aaron Richterman

https://www.sciencedirect.com/science/article/pii/S0891552022000174/pdfft?md5=5d16ecc1cb84b36e711af7e2d70a1139&pid=1-s2.0-S0891552022000174-main.pdf

 

15. Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike – ACE2 complexes reveal distinct changes between both variants

Computational and Structural Biotechnology Journal, 26 February 2022, Volume 20 (Cover date: 2022), Pages 1168-1176

Eileen Socher, Lukas Heger, Philipp Arnold

https://www.sciencedirect.com/science/article/pii/S2001037022000551/pdfft?md5=be588312d3378f3e5d71bd78c97bde04&pid=1-s2.0-S2001037022000551-main.pdf

 

16. Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations

The Lancet Regional Health - Americas, 25 November 2021, Volume 5 (Cover date: January 2022), Article 100133

Jennifer R. Head, Kristin L. Andrejko, Justin V. Remais

https://www.sciencedirect.com/science/article/pii/S2667193X21001290/pdfft?md5=288c40f9ebeca1e72f60b14b74d70cb7&pid=1-s2.0-S2667193X21001290-main.pdf

 

Các công bố về COVID-19 trước thời gian trên:

 

Cập nhật các công bố về COVID-19 từ ngày 25/03 đến ngày 04/03/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nhung-nghien-cuu-phan-tich-ve-covid-19-ngay-25-2-4-3-2022-4729.html

 

Cập nhật các công bố về COVID-19 từ ngày 18/02 đến ngày 25/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/vac-xin-covid-19-va-nhung-xu-huong-nghien-cuu-ngay-18-2-25-2-2022-4707.html

 

Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html

 

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

 

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

 

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

 

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html

 

Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html

 

Nguồn: Cục Thông tin KH&CN quốc gia

Lượt xem: 5284

Tìm theo ngày :

Đánh giá

(Di chuột vào ngôi sao để chọn điểm)